Oncology
Dr Michael Bauer on Quantro’s mission to drug the “undruggab...
Jonah Comstock reunited with Dr Michael Bauer, CEO of Quantro Therapeutics, at LSX 2026 to discuss the company's progress.
R&D
Bioconvergence & future human health, with Shai Melcer
Shai Melcer discusses bioconvergence, a multidisciplinary research and development approach that merges technologies.
Digital
Beyond AI pilots: Pharma needs AI-native operating models, n...
Industry must build custom solutions that leverage a pharmaceutical business’ unique assets – including its people.
Oncology
In vivo CAR-T can solve the delivery problem – but solid tum...
A new generation of in vivo CAR-T cell technologies promises to remove some of the biggest practical barriers to conventional cell therapy.
Oncology
Unlocking the scalability of allogeneic CAR-T
Allogeneic CAR-T, built from healthy donor T-cells, offers a different path toward scale, accessibility, and consistency.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
